PharmaCyte Biotech’s live-cell encapsulation technology, called Cell-in-a-Box, can act both as an artificial pancreas and an artificial liver. Thus, the tech can be used in the treatment of Type 1 and ...
LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results